首页> 外文期刊>Transfusion medicine >The contribution and potential of older blood donors in Asia Pacific regions
【24h】

The contribution and potential of older blood donors in Asia Pacific regions

机译:亚太地区老年献血者的贡献和潜力

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Abstract Objectives To investigate the blood supply contribution of older donors in five Asia Pacific regions. Background Older people are often the largest blood user group. Thus, as the population ages blood supply needs increase. Minimum and maximum donation age criteria potentially constrain the size of the donor pool. Materials and methods Haemoglobin values and demographic frequency analytics (sex, age and blood type) were analysed on blood donors aged 60?years or more, from Hong Kong, Indonesia, Japan, Singapore and South Korea over 12?months. Results Data on ?434357 donations was analysed. ABO Rh(D) frequencies of older donors matched that of national frequencies. Older donors were a disproportionately smaller proportion of the total donor pool for each country. Indonesia was the only region with no maximum age limit. Median haemoglobin for older males ranged from 14.2 to 14.8?g/dl and for females 13.1 to 13.9?g/dl. The frequency of female donors was between 15 and 33 of older donors. Older donors had higher donation frequency and lower deferral rates. Conclusion Older donors are loyal and regular donors but under‐represented in all regions studied. They could help meet future blood supply needs, especially post‐menopausal female donors. Studies including ferritin levels are needed to determine if upper age limits can be safely modified.
机译:摘要 目的 了解亚太地区5个地区老年献血者的血液供应贡献情况。背景:老年人通常是最大的血液使用者群体。因此,随着人口老龄化,血液供应需求增加。最低和最长捐赠年龄标准可能会限制捐赠者群体的规模。材料和方法 对来自香港、印度尼西亚、日本、新加坡和韩国的 60 岁或以上的献血者进行为期 12 个月的血红蛋白值和人口统计频率分析(性别、年龄和血型)。结果 分析了434357捐赠数据。老年捐献者的ABO Rh(D)频率与国家频率一致。老年捐助方在每个国家捐助方总数中所占比例小得不成比例。印度尼西亚是唯一一个没有最高年龄限制的地区。老年男性的中位血红蛋白范围为 14.2 至 14.8?g/dl,女性为 13.1 至 13.9?g/dl。女性捐献者的频率在老年捐献者的15%至33%之间。老年捐献者的捐献频率较高,递延率较低。结论 老年捐献者是忠诚的定期捐献者,但在所研究的所有地区中代表性不足。它们可以帮助满足未来的血液供应需求,尤其是绝经后的女性献血者。需要包括铁蛋白水平在内的研究来确定是否可以安全地修改年龄上限。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号